A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport's syndrome.
Kidney Int
; 97(6): 1275-1286, 2020 06.
Article
in En
| MEDLINE
| ID: mdl-32299679
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Ramipril
/
Nephritis, Hereditary
Type of study:
Clinical_trials
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Child
/
Humans
Language:
En
Journal:
Kidney Int
Year:
2020
Type:
Article